Traditional methods of bacterial endotoxin test and its challenges
Bacterial endotoxins are components of the cell wall of Gram-negative bacteria. They are released when the bacteria die or lyse, and are potentially harmful to humans and animals, such as causing endotoxin shock and inflammation. In the production process of drugs, medical devices and biological products, it is crucial to strictly control the level of bacterial endotoxins.
Traditional bacterial endotoxin detection mainly relies on LAL reagents extracted from horseshoe crab blood. The principle of LAL reagent for endotoxin detection is based on the coagulation of horseshoe crab blood cells (amoebae cells) in the presence of low levels of endotoxins. Specifically, when endotoxins meet LAL reagents, a series of enzymatic reactions are triggered, and finally a gel-like clot is formed (gel-forming), which is used to determine the presence and content of endotoxins. Since this method was discovered in the 1950s, it has become the industry standard for endotoxin detection in the pharmaceutical and food industries, as well as in life science and medical research due to its economic, specific and sensitive characteristics. However, as a rare marine organism, the horseshoe crab population has been reduced due to overfishing for LAL reagent production. The shortage of horseshoe crab resources has made bacterial endotoxin detection based on LAL reagents face severe challenges, and the entire industry is in urgent need of sustainable alternatives.
💡The rise of recombinant reagents as an alternative
In order to solve the problem of horseshoe crab resource shortage, recombinant reagents came into being. Recombinant reagents use genetic engineering methods to prepare key proteases in LAL reagents to synthesize recombinant endotoxin detection reagents. This technical route does not rely on animal-derived ingredients, fundamentally avoiding dependence on horseshoe crab resources, and has the significant advantage of sustainable and stable supply.
Recombinant factor C (rFC) reagent is one of the early recombinant BET alternatives. It uses genetic recombination technology to express factor C in horseshoe crab blood cells. Factor C binds to endotoxins and is activated to trigger subsequent reactions, thereby realizing the detection of endotoxins. Although rFC reagents have made certain technical progress and solved some sustainability issues, they have limitations in performance, such as insufficient detection accuracy for certain complex samples and the need to improve sensitivity, which has led to its failure to be widely adopted in the industry in the 20 years since its launch.
🔬Working principle and advantages of recombinant cascade reagent (rCR)
As a new generation of recombinant BET technology, recombinant cascade reagent (rCR) has achieved major breakthroughs in principle and performance. Taking the genetic recombinant cascade reagent colorimetric method as an example, it uses genetic recombination technology to express serine protease catalytic cascade proteins in horseshoe crab blood cells that can react with endotoxins in eukaryotic cells, including Factor C, Factor B, and proclotting enzyme. Its working mechanism is as follows: When recombinant Factor C binds to endotoxin and is activated, it activates Factor B, and the activated Factor B activates proclotting enzyme, turning it into a biologically active coagulase. Finally, the coagulase recognizes and catalyzes the downstream substrate with a chromogenic group to produce a color reaction. The intensity of the color reaction is positively correlated with the endotoxin concentration, thereby achieving quantitative detection of endotoxins.
✨Compared with traditional LAL reagents and early rFC reagents, recombinant cascade reagents (rCR) have many significant advantages:
High sensitivity: rCR reagents are extremely sensitive, and some products can be as sensitive as 0.001EU/ml. Compared with some traditional LAL reagents and rFC reagents, they can detect lower concentrations of endotoxins, greatly improving the accuracy and reliability of detection. They are especially suitable for the detection of drugs and biological products with extremely strict requirements on bacterial endotoxin levels.
Excellent stability: rCR reagents have good batch-to-batch reproducibility. Due to the use of genetic engineering technology, its production process can be precisely controlled, and the quality and performance of each batch of products can be highly consistent, reducing the fluctuation of test results caused by differences in reagent batches, providing laboratories and manufacturers with more stable and reliable detection tools.
Strong specificity: rCR reagents do not react with fungal (1,3)-β-D-glucan, effectively avoiding false positive results caused by factor G bypass. In actual testing, there may be a variety of impurities in the sample. Fungal (1,3)-β-D-glucan is a common interfering substance. Traditional detection methods may cause misjudgment due to its presence. The high specificity of rCR reagents ensures the accuracy of the test results and reduces the cost waste caused by unnecessary repeated testing and misjudgment.
Convenient detection: rCR reagents and colorimetric horseshoe crab reagents use the same detection equipment, and there is no need to replace the detection equipment. For laboratories and enterprises that have established chromogenic LAL reagent detection systems, it is easy to upgrade the detection technology, reduce the cost of technology conversion and operation difficulty, and is conducive to the rapid promotion and application of rCR reagents in the industry.
Sustainability: rCR reagents completely get rid of the dependence on horseshoe crab blood, and solve the problem of horseshoe crab resource shortage faced by traditional LAL reagents from the source. It is in line with the concept of sustainable development and provides a strong guarantee for the long-term and stable development of the bacterial endotoxin detection industry.
📈The current situation and development prospects of recombinant cascade reagents (rCR)
At present, recombinant cascade reagents (rCR) are in a rapid development stage. Although it has many advantages in performance, it still faces some challenges in the promotion process. On the one hand, as it is an emerging technology, some laboratories and enterprises have limited understanding of it, and it is necessary to strengthen technical publicity and training to improve the industry's awareness of rCR reagents. On the other hand, regulatory agencies have strict approval processes and standards for new detection technologies and reagents. rCR reagents need to pass a series of rigorous comparability studies and performance verification to prove that they have equivalent or even better performance than traditional LAL reagents, so as to obtain the recognition and approval of regulatory agencies.
However, with the increasing attention paid by various countries to sustainable development and the continuous strengthening of quality and safety supervision of drugs and biological products, the development prospects of recombinant cascade reagents (rCR) are very broad. USP (United States Pharmacopeia) has officially included recombinant reagents in the BET test standard. This milestone has injected strong impetus into the promotion and application of rCR reagents, indicating that this emerging technology will soon be more widely accepted by the industry. More and more scientific research institutions and enterprises have begun to pay attention to and invest resources in the research and application development of rCR reagents. As the technology continues to mature and improve, rCR reagents are expected to occupy an important position in the field of bacterial endotoxin detection, reshape the industry landscape, and provide more reliable and sustainable technical support to ensure the safety of drugs, medical devices and biological products.